130 related articles for article (PubMed ID: 21073472)
1. Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity.
Hefti M; Holenstein F; Albert I; Looser H; Luginbuehl V
Photochem Photobiol; 2011; 87(1):235-41. PubMed ID: 21073472
[TBL] [Abstract][Full Text] [Related]
2. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin.
Ohgari Y; Nakayasu Y; Kitajima S; Sawamoto M; Mori H; Shimokawa O; Matsui H; Taketani S
Biochem Pharmacol; 2005 Dec; 71(1-2):42-9. PubMed ID: 16288996
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
Mansi M; Howley R; Chandratre S; Chen B
Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
[TBL] [Abstract][Full Text] [Related]
5. Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells.
Tsai T; Hong RL; Tsai JC; Lou PJ; Ling IF; Chen CT
Lasers Surg Med; 2004; 34(1):62-72. PubMed ID: 14755426
[TBL] [Abstract][Full Text] [Related]
6. Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine.
Palasuberniam P; Kraus D; Mansi M; Braun A; Howley R; Myers KA; Chen B
Photochem Photobiol; 2019 Jul; 95(4):1052-1059. PubMed ID: 30767226
[TBL] [Abstract][Full Text] [Related]
7. Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy.
Casas A; Fukuda H; Di Venosa G; Batlle A
Br J Cancer; 2001 Jul; 85(2):279-84. PubMed ID: 11461090
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
[TBL] [Abstract][Full Text] [Related]
10. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
[TBL] [Abstract][Full Text] [Related]
11. In vitro resistance of articular chondrocytes to 5-Aminolevulinic acid based photodynamic therapy.
Egli RJ; Di Criscio A; Hempfing A; Schoeniger R; Ganz R; Hofstetter W; Leunig M
Lasers Surg Med; 2008 Apr; 40(4):282-90. PubMed ID: 18412230
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of protoporphyrin-IX (PpIX) in leukemic cell lines following induction by 5-aminolevulinic acid (ALA).
Bartosová J; Hrkal Z
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jul; 126(3):245-52. PubMed ID: 11048674
[TBL] [Abstract][Full Text] [Related]
13. Enhancing the effect of 5-aminolevulinic acid based photodynamic therapy in human meningioma cells.
Cornelius JF; Slotty PJ; El Khatib M; Giannakis A; Senger B; Steiger HJ
Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):1-6. PubMed ID: 24486853
[TBL] [Abstract][Full Text] [Related]
14. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin.
Wiegell SR; Stender IM; Na R; Wulf HC
Arch Dermatol; 2003 Sep; 139(9):1173-7. PubMed ID: 12975159
[TBL] [Abstract][Full Text] [Related]
15. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas.
Inoue K; Karashima T; Kamada M; Shuin T; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J
Pathobiology; 2009; 76(6):303-14. PubMed ID: 19955842
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of cell death by 5-aminolevulinic acid-based photodynamic action and its enhancement by ferrochelatase inhibitors in human histiocytic lymphoma cell line U937.
Amo T; Kawanishi N; Uchida M; Fujita H; Oyanagi E; Utsumi T; Ogino T; Inoue K; Shuin T; Utsumi K; Sasaki J
Cell Biochem Funct; 2009 Dec; 27(8):503-15. PubMed ID: 19735078
[TBL] [Abstract][Full Text] [Related]
17. The advantages of aminolevulinic acid photodynamic therapy in dermatology.
Taylor EL; Brown SB
J Dermatolog Treat; 2002; 13 Suppl 1():S3-11. PubMed ID: 12060511
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
[TBL] [Abstract][Full Text] [Related]
19. Methods to Measure the Inhibition of ABCG2 Transporter and Ferrochelatase Activity to Enhance Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Tumor Detection and Resection.
Mansi M; Howley R; Chen B
Methods Mol Biol; 2022; 2394():823-835. PubMed ID: 35094360
[TBL] [Abstract][Full Text] [Related]
20. [Role of calcium signal in apoptosis and protective mechanism of colon cancer cell line SW480 in response to 5-aminolevulinic acid-photodynamic therapy].
Zheng JH; Shi D; Zhao Y; Chen ZL
Ai Zheng; 2006 Jun; 25(6):683-8. PubMed ID: 16764761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
